Funding for this research was provided by:
National Institute of Biomedical Imaging and Bioengineering (R21EB026035)
Directorate for Engineering (CBET-1943696)
Received: 11 June 2020
Accepted: 19 April 2021
First Online: 29 May 2021
: Human pluripotent stem cell experiments were approved by the Embryonic Stem Cell Oversight Committee at the Pennsylvania State University and carried out in accordance with the approved guidelines. All hPSC lines were obtained from WiCell.
: Not applicable.
: The authors declare that they have no competing interests.